Inventor
FLEURY MELISSA
US98 patents
⚠️ This page may combine multiple inventors who share the name “FLEURY MELISSA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
THERAVANCE BIOPHARMA R&D IP LLC
24 patentsUS10526330B2Jan 7, 2020
JAK kinase inhibitor compounds for treatment of respiratory disease
THERAVANCE BIOPHARMA R&D IP LLC15 citations94
US10189823B2Jan 29, 2019
Neprilysin inhibitors
THERAVANCE BIOPHARMA R&D IP LLC9 citations93
US10100049B2Oct 16, 2018
JAK kinase inhibitor compounds for treatment of respiratory disease
THERAVANCE BIOPHARMA R&D IP LLC28 citations93
US10028960B2Jul 24, 2018
Pyrimidine compounds as JAK kinase inhibitors
THERAVANCE BIOPHARMA R&D IP LLC18 citations93
US9873685B2Jan 23, 2018
Neprilysin inhibitors
THERAVANCE BIOPHARMA R&D IP LLC10 citations93
US9725470B2Aug 8, 2017
Substituted naphthyridines as JAK kinase inhibitors
THERAVANCE BIOPHARMA R&D IP LLC27 citations93
US10570120B2Feb 25, 2020
Neprilysin inhibitors
THERAVANCE BIOPHARMA R&D IP LLC6 citations84
US10172834B2Jan 8, 2019
(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid
THERAVANCE BIOPHARMA R&D IP LLC3 citations84
US10123984B2Nov 13, 2018
Neprilysin inhibitors
THERAVANCE BIOPHARMA R&D IP LLC3 citations84
US9884807B2Feb 6, 2018
Neprilysin inhibitors
THERAVANCE BIOPHARMA R&D IP LLC3 citations84
US9872855B2Jan 23, 2018
(2R,4R)-5-(5′-Chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid
THERAVANCE BIOPHARMA R&D IP LLC5 citations84
US9845332B2Dec 19, 2017
Neprilysin inhibitors
THERAVANCE BIOPHARMA R&D IP LLC7 citations84
US9688692B2Jun 27, 2017
Neprilysin inhibitors
THERAVANCE BIOPHARMA R&D IP LLC7 citations84
US9533962B2Jan 3, 2017
(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid
THERAVANCE BIOPHARMA R&D IP LLC6 citations84
US10752599B2Aug 25, 2020
Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof
THERAVANCE BIOPHARMA R&D IP LLC3 citations82
US10472335B2Nov 12, 2019
Crystalline(2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-bipheny]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof
THERAVANCE BIOPHARMA R&D IP LLC4 citations82
US10100021B2Oct 16, 2018
Crystalline(2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof
THERAVANCE BIOPHARMA R&D IP LLC4 citations82
US11299492B2Apr 12, 2022
JAK kinase inhibitor compounds for treatment of respiratory disease
THERAVANCE BIOPHARMA R&D IP LLC2 citations73
US11261197B2Mar 1, 2022
Neprilysin inhibitors
THERAVANCE BIOPHARMA R&D IP LLC1 citations73
US11230536B2Jan 25, 2022
Crystalline (2S,4R)-5-(5′-chloro-2′-fluoro-[1,1′-biphenyl]-4-yl)-2-(ethoxymethyl)-4-(3-hydroxyisoxazole-5-carboxamido)-2-methylpentanoic acid and uses thereof
THERAVANCE BIOPHARMA R&D IP LLC2 citations73
US11124502B2Sep 21, 2021
Neprilysin inhibitors
THERAVANCE BIOPHARMA R&D IP LLC2 citations73
US11033533B2Jun 15, 2021
(2R,4R)-5-(5′-chloro-2′-fluorobiphenyl-4-yl)-2-hydroxy-4-[(5-methyloxazole-2-carbonyl)amino]pentanoic acid
THERAVANCE BIOPHARMA R&D IP LLC1 citations73
US10829438B2Nov 10, 2020
Neprilysin inhibitors
THERAVANCE BIOPHARMA R&D IP LLC1 citations73
US10744104B2Aug 18, 2020
Neprilysin inhibitors
THERAVANCE BIOPHARMA R&D IP LLC2 citations73
FLEURY MELISSA
6 patentsUS9126956B2Sep 8, 2015
Neprilysin inhibitors
FLEURY MELISSA51 citations98
US8481044B2Jul 9, 2013
Neprilysin inhibitors
FLEURY MELISSA67 citations98
US8449890B2May 28, 2013
Neprilysin inhibitors
FLEURY MELISSA68 citations98
US8686184B2Apr 1, 2014
Neprilysin inhibitors
FLEURY MELISSA61 citations97
US9670186B2Jun 6, 2017
Neprilysin inhibitors
FLEURY MELISSA12 citations92
US9499487B2Nov 22, 2016
Neprilysin inhibitors
FLEURY MELISSA12 citations84
HUGHES ADAM D
5 patentsUS9108934B2Aug 18, 2015
Neprilysin inhibitors
HUGHES ADAM D51 citations98
US8871792B2Oct 28, 2014
Neprilysin inhibitors
HUGHES ADAM D53 citations98
US8691868B2Apr 8, 2014
Neprilysin inhibitors
HUGHES ADAM D57 citations98
US9682052B2Jun 20, 2017
Neprilysin inhibitors
HUGHES ADAM D4 citations84
US9150500B2Oct 6, 2015
Neprilysin inhibitors
HUGHES ADAM D5 citations84
THERAVANCE RESPIRATORY CO LLC
4 patentsUS9975875B2May 22, 2018
Diamide compounds having muscarinic receptor antagonist and Beta2 adrenergic receptor agonist activity
THERAVANCE RESPIRATORY CO LLC4 citations84
US9771350B2Sep 26, 2017
Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity
THERAVANCE RESPIRATORY CO LLC4 citations84
US9682957B2Jun 20, 2017
Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity
THERAVANCE RESPIRATORY CO LLC5 citations84
US9572802B2Feb 21, 2017
Diamide compounds having muscarinic receptor antagonist and β2 adrenergic receptor agonist activity
THERAVANCE RESPIRATORY CO LLC5 citations84
GENDRON ROLAND
3 patentsTHERAVANCE INC
2 patentsFENSTER ERIK
2 patentsSMITH CAMERON
1 patentHUGHES ADAM
1 patentGILEAD SCIENCES INC
1 patentBLAIR BROOKE
1 patentShowing the top 50 of 98 patents by PatentIndex Score.